I just want this out of the way...its just a side act. Has UNS and its customers addressed and resolved the issues from 2015?
By issues i mean the reasons why UNS was sooo far away from meeting the expected earnings required by Orbimed covenants.
Are the programs simply delayed or progressing slower than anticipated or have they cancelled and dried up/drugs fallen over in trials.
It was woeful that in calendar 2015 we hoped to shop 1 million Unifill...from a company that has told the market repeatedly that they are installing, have installed lines that are largely all reserved-booked by customers and yet we find ourselves here earning a measly 850k a month from all these programs they claim could allow the company to break even if they wanted
Any amongst all the talk of extension...Orbimed are still floating aeiund waiting for payments. So again..are the Directors pulling wages again?
- Forums
- ASX - By Stock
- UNS
- Announcements
Announcements, page-44
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)